▶ 調査レポート

エルロチニブ塩酸塩の世界市場レポート2020

• 英文タイトル:Global Erlotinib Hydrochloride Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。エルロチニブ塩酸塩の世界市場レポート2020 / Global Erlotinib Hydrochloride Sales Market Report 2020 / 20QY06-01082資料のイメージです。• レポートコード:20QY06-01082
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:化学・材料
• 販売価格(消費税別)
  Single User¥560,000 (USD4,000)▷ お問い合わせ
  Multi User¥840,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,120,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、エルロチニブ塩酸塩のグローバル市場について種類別(25mg錠、100mg錠、150mg錠)、用途別(非小細胞肺がん(NSCLC)、膵臓がん、その他の種類のがん)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・エルロチニブ塩酸塩市場の概要
・世界の主要地域別エルロチニブ塩酸塩市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のエルロチニブ塩酸塩市場規模2015-2026:種類別(25mg錠、100mg錠、150mg錠)
・世界のエルロチニブ塩酸塩市場規模2015-2026:用途別(非小細胞肺がん(NSCLC)、膵臓がん、その他の種類のがん)
・エルロチニブ塩酸塩の北米市場規模2015-2020
・エルロチニブ塩酸塩のヨーロッパ市場規模2015-2020
・エルロチニブ塩酸塩の中国市場規模2015-2020
・エルロチニブ塩酸塩の日本市場規模2015-2020
・エルロチニブ塩酸塩の東南アジア市場規模2015-2020
・エルロチニブ塩酸塩のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(HEC Pharm、Arasto Pharmaceutical Chemicals Inc.、Tava、Polpharma Pharmaceutical Works、Suanfarma、Natco Pharma、Tecoland、Shanghai Biosundrug Co., Ltd.、Shilpa Medicare Ltd.)
・エルロチニブ塩酸塩の製造コスト分析
・販売チャネル、流通業者、顧客
・エルロチニブ塩酸塩の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Erlotinib Hydrochloride Market
The global Erlotinib Hydrochloride market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Erlotinib Hydrochloride Scope and Market Size
The global Erlotinib Hydrochloride market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erlotinib Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Erlotinib Hydrochloride market is segmented into
25 mg tablet
100 mg tablet
150 mg tablet

Segment by Application, the Erlotinib Hydrochloride market is segmented into
Non-Small Cell Lung Cancer (NSCLC)
Pancreatic Cancer
Other Types of Cancer
The Erlotinib Hydrochloride market is analysed and market size information is provided by regions (countries). Segment by Application, the Erlotinib Hydrochloride market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Erlotinib Hydrochloride Market Share Analysis
Erlotinib Hydrochloride market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Erlotinib Hydrochloride business, the date to enter into the Erlotinib Hydrochloride market, Erlotinib Hydrochloride product introduction, recent developments, etc.
The major vendors covered:
HEC Pharm
Arasto Pharmaceutical Chemicals Inc.
Tava
Polpharma Pharmaceutical Works
Suanfarma
Natco Pharma
Tecoland
Shanghai Biosundrug Co., Ltd.
Shilpa Medicare Ltd.

レポート目次

Table of Contents

1 Erlotinib Hydrochloride Market Overview
1.1 Erlotinib Hydrochloride Product Scope
1.2 Erlotinib Hydrochloride Segment by Type
1.2.1 Global Erlotinib Hydrochloride Sales by Type (2020-2026)
1.2.2 25 mg tablet
1.2.3 100 mg tablet
1.2.4 150 mg tablet
1.3 Erlotinib Hydrochloride Segment by Application
1.3.1 Global Erlotinib Hydrochloride Sales Comparison by Application (2020-2026)
1.3.2 Non-Small Cell Lung Cancer (NSCLC)
1.3.3 Pancreatic Cancer
1.3.4 Other Types of Cancer
1.4 Erlotinib Hydrochloride Market Estimates and Forecasts (2015-2026)
1.4.1 Global Erlotinib Hydrochloride Sales Growth Rate (2015-2026)
1.4.2 Global Erlotinib Hydrochloride Revenue and Growth Rate (2015-2026)
1.4.3 Global Erlotinib Hydrochloride Price Trends (2015-2026)

2 Erlotinib Hydrochloride Estimate and Forecast by Region
2.1 Global Erlotinib Hydrochloride Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Erlotinib Hydrochloride Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Erlotinib Hydrochloride Sales Market Share by Region (2015-2020)
2.2.2 Global Erlotinib Hydrochloride Revenue Market Share by Region (2015-2020)
2.3 Global Erlotinib Hydrochloride Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Erlotinib Hydrochloride Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Erlotinib Hydrochloride Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Erlotinib Hydrochloride Estimates and Projections (2015-2026)
2.4.2 Europe Erlotinib Hydrochloride Estimates and Projections (2015-2026)
2.4.3 China Erlotinib Hydrochloride Estimates and Projections (2015-2026)
2.4.4 Japan Erlotinib Hydrochloride Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Erlotinib Hydrochloride Estimates and Projections (2015-2026)
2.4.6 India Erlotinib Hydrochloride Estimates and Projections (2015-2026)
3 Global Erlotinib Hydrochloride Competition Landscape by Players
3.1 Global Top Erlotinib Hydrochloride Players by Sales (2015-2020)
3.2 Global Top Erlotinib Hydrochloride Players by Revenue (2015-2020)
3.3 Global Erlotinib Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erlotinib Hydrochloride as of 2019)
3.4 Global Erlotinib Hydrochloride Average Price by Company (2015-2020)
3.5 Manufacturers Erlotinib Hydrochloride Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Erlotinib Hydrochloride Players (Opinion Leaders)
4 Global Erlotinib Hydrochloride Market Size by Type
4.1 Global Erlotinib Hydrochloride Historic Market Review by Type (2015-2020)
4.1.1 Global Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
4.1.2 Global Erlotinib Hydrochloride Revenue Market Share by Type (2015-2020)
4.1.3 Global Erlotinib Hydrochloride Price by Type (2014-2020)
4.2 Global Erlotinib Hydrochloride Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Erlotinib Hydrochloride Sales Forecast by Type (2021-2026)
4.2.2 Global Erlotinib Hydrochloride Revenue Forecast by Type (2021-2026)
4.2.3 Global Erlotinib Hydrochloride Price Forecast by Type (2021-2026)
5 Global Erlotinib Hydrochloride Market Size by Application
5.1 Global Erlotinib Hydrochloride Historic Market Review by Application (2015-2020)
5.1.1 Global Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)
5.1.2 Global Erlotinib Hydrochloride Revenue Market Share by Application (2015-2020)
5.1.3 Global Erlotinib Hydrochloride Price by Application (2015-2020)
5.2 Global Erlotinib Hydrochloride Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Erlotinib Hydrochloride Sales Forecast by Application (2021-2026)
5.2.2 Global Erlotinib Hydrochloride Revenue Forecast by Application (2021-2026)
5.2.3 Global Erlotinib Hydrochloride Price Forecast by Application (2021-2026)

3 North America Erlotinib Hydrochloride Market Facts & Figures
3.2 North America Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
3.3 North America Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
3.4 North America Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)

4 Europe Erlotinib Hydrochloride Market Facts & Figures
4.2 Europe Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
4.3 Europe Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
4.4 Europe Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)

5 China Erlotinib Hydrochloride Market Facts & Figures
5.2 China Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
5.3 China Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
5.4 China Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)

6 Japan Erlotinib Hydrochloride Market Facts & Figures
6.2 Japan Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
6.3 Japan Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
6.4 Japan Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)

7 Southeast Asia Erlotinib Hydrochloride Market Facts & Figures
7.2 Southeast Asia Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)

8 India Erlotinib Hydrochloride Market Facts & Figures
8.2 India Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
8.3 India Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
8.4 India Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Erlotinib Hydrochloride Business
12.1 HEC Pharm
12.1.1 HEC Pharm Erlotinib Hydrochloride Corporation Information
12.1.2 HEC Pharm Erlotinib Hydrochloride Business Overview and Total Revenue
12.1.3 HEC Pharm Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.1.4 HEC Pharm Erlotinib Hydrochloride Products Offered
12.1.5 HEC Pharm Recent Development
12.2 Arasto Pharmaceutical Chemicals Inc.
12.2.1 Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Corporation Information
12.2.2 Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Business Overview and Total Revenue
12.2.3 Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Products Offered
12.2.5 Arasto Pharmaceutical Chemicals Inc. Recent Development
12.3 Tava
12.3.1 Tava Erlotinib Hydrochloride Corporation Information
12.3.2 Tava Erlotinib Hydrochloride Business Overview and Total Revenue
12.3.3 Tava Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Tava Erlotinib Hydrochloride Products Offered
12.3.5 Tava Recent Development
12.4 Polpharma Pharmaceutical Works
12.4.1 Polpharma Pharmaceutical Works Erlotinib Hydrochloride Corporation Information
12.4.2 Polpharma Pharmaceutical Works Erlotinib Hydrochloride Business Overview and Total Revenue
12.4.3 Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Polpharma Pharmaceutical Works Erlotinib Hydrochloride Products Offered
12.4.5 Polpharma Pharmaceutical Works Recent Development
12.5 Suanfarma
12.5.1 Suanfarma Erlotinib Hydrochloride Corporation Information
12.5.2 Suanfarma Erlotinib Hydrochloride Business Overview and Total Revenue
12.5.3 Suanfarma Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Suanfarma Erlotinib Hydrochloride Products Offered
12.5.5 Suanfarma Recent Development
12.6 Natco Pharma
12.6.1 Natco Pharma Erlotinib Hydrochloride Corporation Information
12.6.2 Natco Pharma Erlotinib Hydrochloride Business Overview and Total Revenue
12.6.3 Natco Pharma Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Natco Pharma Erlotinib Hydrochloride Products Offered
12.6.5 Natco Pharma Recent Development
12.7 Tecoland
12.7.1 Tecoland Erlotinib Hydrochloride Corporation Information
12.7.2 Tecoland Erlotinib Hydrochloride Business Overview and Total Revenue
12.7.3 Tecoland Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Tecoland Erlotinib Hydrochloride Products Offered
12.7.5 Tecoland Recent Development
12.8 Shanghai Biosundrug Co., Ltd.
12.8.1 Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Corporation Information
12.8.2 Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Business Overview and Total Revenue
12.8.3 Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Products Offered
12.8.5 Shanghai Biosundrug Co., Ltd. Recent Development
12.9 Shilpa Medicare Ltd.
12.9.1 Shilpa Medicare Ltd. Erlotinib Hydrochloride Corporation Information
12.9.2 Shilpa Medicare Ltd. Erlotinib Hydrochloride Business Overview and Total Revenue
12.9.3 Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Shilpa Medicare Ltd. Erlotinib Hydrochloride Products Offered
12.9.5 Shilpa Medicare Ltd. Recent Development

13 Erlotinib Hydrochloride Manufacturing Cost Analysis
13.1 Erlotinib Hydrochloride Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Erlotinib Hydrochloride
13.4 Erlotinib Hydrochloride Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Erlotinib Hydrochloride Distributors List
14.3 Erlotinib Hydrochloride Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Erlotinib Hydrochloride Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Erlotinib Hydrochloride Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Erlotinib Hydrochloride Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Erlotinib Hydrochloride Sales (K MT) by Region (2015-2020)
Table 5. Global Erlotinib Hydrochloride Sales Market Share by Region (2015-2020)
Table 6. Global Erlotinib Hydrochloride Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Erlotinib Hydrochloride Revenue Share by Region (2015-2020)
Table 8. Global Erlotinib Hydrochloride Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Erlotinib Hydrochloride Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Erlotinib Hydrochloride Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Erlotinib Hydrochloride Revenue Share Forecast by Region (2021-2026)
Table 12. Global Erlotinib Hydrochloride (K MT) of Key Companies (2015-2020)
Table 13. Global Erlotinib Hydrochloride Sales Share by Company (2015-2020)
Table 14. Global Erlotinib Hydrochloride Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Erlotinib Hydrochloride Revenue Share by Company (2015-2020)
Table 16. Global Erlotinib Hydrochloride by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erlotinib Hydrochloride as of 2019)
Table 17. Global Erlotinib Hydrochloride Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Erlotinib Hydrochloride Manufacturing Sites and Area Served
Table 19. Manufacturers Erlotinib Hydrochloride Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Erlotinib Hydrochloride Players
Table 22. Global Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 23. Global Erlotinib Hydrochloride Sales Share by Type (2015-2020)
Table 24. Global Erlotinib Hydrochloride Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Erlotinib Hydrochloride Price (K MT) by Type (2015-2020)
Table 26. Global Erlotinib Hydrochloride Sales Share by Type (2021-2026)
Table 27. Global Erlotinib Hydrochloride Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Erlotinib Hydrochloride Revenue Share by Type (2021-2026)
Table 29. Global Erlotinib Hydrochloride Price (K MT) by Type (2021-2026)
Table 30. Global Erlotinib Hydrochloride Sales (K MT) by Application (2015-2020)
Table 31. Global Erlotinib Hydrochloride Sales Share by Application (2015-2020)
Table 32. Global Erlotinib Hydrochloride Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Erlotinib Hydrochloride Price (K MT) by Application (2015-2020)
Table 34. Global Erlotinib Hydrochloride Sales (K MT) by Application (2021-2026)
Table 35. Global Erlotinib Hydrochloride Sales Share by Application (2021-2026)
Table 36. Global Erlotinib Hydrochloride Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Erlotinib Hydrochloride Revenue Share by Application (2021-2026)
Table 38. Global Erlotinib Hydrochloride Price (K MT) by Application (2021-2026)
Table 39. United States Erlotinib Hydrochloride Sales (K MT) by Company (2015-2020)
Table 40. United States Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
Table 41. United States Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 42. United States Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
Table 43. United States Erlotinib Hydrochloride Sales (K MT) by Application (2015-2020)
Table 44. United States Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)
Table 45. Europe Erlotinib Hydrochloride Sales (K MT) by Company (2015-2020)
Table 46. Europe Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
Table 47. Europe Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 48. Europe Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
Table 49. Europe Erlotinib Hydrochloride Sales (K MT) by Application (2015-2020)
Table 50. Europe Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
Table 51. China Erlotinib Hydrochloride Sales (K MT) by Company (2015-2020)
Table 52. China Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
Table 53. China Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 54. China Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
Table 55. China Erlotinib Hydrochloride Sales (K MT) by Application (2015-2020)
Table 56. China Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)
Table 57. Japan Erlotinib Hydrochloride Sales (K MT) by Company (2015-2020)
Table 58. Japan Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
Table 59. Japan Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 60. Japan Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
Table 61. Japan Erlotinib Hydrochloride Sales (K MT) by Application (2015-2020)
Table 62. Japan Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Erlotinib Hydrochloride Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)
Table 69. India Erlotinib Hydrochloride Sales (K MT) by Company (2015-2020)
Table 70. India Erlotinib Hydrochloride Sales Market Share by Company (2015-2020)
Table 71. India Erlotinib Hydrochloride Sales (K MT) by Type (2015-2020)
Table 72. India Erlotinib Hydrochloride Sales Market Share by Type (2015-2020)
Table 73. India Erlotinib Hydrochloride Sales (K MT) by Application (2015-2020)
Table 74. India Erlotinib Hydrochloride Sales Market Share by Application (2015-2020)
Table 75. HEC Pharm Corporation Information
Table 76. HEC Pharm Description and Business Overview
Table 77. HEC Pharm Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. HEC Pharm Erlotinib Hydrochloride Product
Table 79. HEC Pharm Recent Development
Table 80. Arasto Pharmaceutical Chemicals Inc. Corporation Information
Table 81. Arasto Pharmaceutical Chemicals Inc. Description and Business Overview
Table 82. Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Product
Table 84. Arasto Pharmaceutical Chemicals Inc. Recent Development
Table 85. Tava Corporation Information
Table 86. Tava Description and Business Overview
Table 87. Tava Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Tava Erlotinib Hydrochloride Product
Table 89. Tava Recent Development
Table 90. Polpharma Pharmaceutical Works Corporation Information
Table 91. Polpharma Pharmaceutical Works Description and Business Overview
Table 92. Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Polpharma Pharmaceutical Works Erlotinib Hydrochloride Product
Table 94. Polpharma Pharmaceutical Works Recent Development
Table 95. Suanfarma Corporation Information
Table 96. Suanfarma Description and Business Overview
Table 97. Suanfarma Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Suanfarma Erlotinib Hydrochloride Product
Table 99. Suanfarma Recent Development
Table 100. Natco Pharma Corporation Information
Table 101. Natco Pharma Description and Business Overview
Table 102. Natco Pharma Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Natco Pharma Erlotinib Hydrochloride Product
Table 104. Natco Pharma Recent Development
Table 105. Tecoland Corporation Information
Table 106. Tecoland Description and Business Overview
Table 107. Tecoland Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Tecoland Erlotinib Hydrochloride Product
Table 109. Tecoland Recent Development
Table 110. Shanghai Biosundrug Co., Ltd. Corporation Information
Table 111. Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Shanghai Biosundrug Co., Ltd. Description and Business Overview
Table 113. Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Product
Table 114. Shanghai Biosundrug Co., Ltd. Recent Development
Table 115. Shilpa Medicare Ltd. Corporation Information
Table 116. Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Shilpa Medicare Ltd. Description and Business Overview
Table 118. Shilpa Medicare Ltd. Erlotinib Hydrochloride Product
Table 119. Shilpa Medicare Ltd. Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Erlotinib Hydrochloride Distributors List
Table 123. Erlotinib Hydrochloride Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Erlotinib Hydrochloride Product Picture
Figure 2. Global Erlotinib Hydrochloride Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Erlotinib Hydrochloride Market Share by Application in 2020 & 2026
Figure 6. Non-Small Cell Lung Cancer (NSCLC) Examples
Figure 7. Pancreatic Cancer Examples
Figure 8. Other Types of Cancer Examples
Figure 9. Global Erlotinib Hydrochloride Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Erlotinib Hydrochloride Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Erlotinib Hydrochloride Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Erlotinib Hydrochloride Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Erlotinib Hydrochloride Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Erlotinib Hydrochloride Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Erlotinib Hydrochloride Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Erlotinib Hydrochloride Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Erlotinib Hydrochloride Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Erlotinib Hydrochloride Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Erlotinib Hydrochloride Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Erlotinib Hydrochloride Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Erlotinib Hydrochloride Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Erlotinib Hydrochloride Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Erlotinib Hydrochloride Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Erlotinib Hydrochloride Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Erlotinib Hydrochloride Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Erlotinib Hydrochloride Players Market Share by Revenue in Erlotinib Hydrochloride 2015 & 2019
Figure 27. Erlotinib Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Erlotinib Hydrochloride Revenue Share by Type (2015-2020)
Figure 29. Global Erlotinib Hydrochloride Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Erlotinib Hydrochloride Revenue Share by Application (2015-2020)
Figure 31. Global Erlotinib Hydrochloride Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Erlotinib Hydrochloride Sales Market Share by Type in 2019
Figure 33. United States Erlotinib Hydrochloride Sales Market Share by Type in 2019
Figure 34. Europe Erlotinib Hydrochloride Sales Market Share by Company in 2019
Figure 35. Europe Erlotinib Hydrochloride Sales Market Share by Type in 2019
Figure 36. Europe Erlotinib Hydrochloride Sales Market Share by Application in 2019
Figure 37. China Erlotinib Hydrochloride Sales Market Share by Company in 2019
Figure 38. China Erlotinib Hydrochloride Sales Market Share by Type in 2019
Figure 39. China Erlotinib Hydrochloride Sales Market Share by Application in 2019
Figure 40. Japan Erlotinib Hydrochloride Sales Market Share by Company in 2019
Figure 41. Japan Erlotinib Hydrochloride Sales Market Share by Type in 2019
Figure 42. Japan Erlotinib Hydrochloride Sales Market Share by Application in 2019
Figure 43. Southeast Asia Erlotinib Hydrochloride Sales Market Share by Company in 2019
Figure 44. Southeast Asia Erlotinib Hydrochloride Sales Market Share by Type in 2019
Figure 45. Southeast Asia Erlotinib Hydrochloride Sales Market Share by Application in 2019
Figure 46. India Erlotinib Hydrochloride Sales Market Share by Company in 2019
Figure 47. India Erlotinib Hydrochloride Sales Market Share by Type in 2019
Figure 48. India Erlotinib Hydrochloride Sales Market Share by Application in 2019
Figure 49. HEC Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Arasto Pharmaceutical Chemicals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Tava Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Polpharma Pharmaceutical Works Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Suanfarma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Natco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Tecoland Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Shanghai Biosundrug Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Shilpa Medicare Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Erlotinib Hydrochloride
Figure 60. Manufacturing Process Analysis of Erlotinib Hydrochloride
Figure 61. Erlotinib Hydrochloride Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed